← Browse by Condition
Medical Condition

lymphoma follicular

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05849857 Phase 2
Recruiting

Mosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic Countries

Enrollment
80 pts
Location
Finland, Norway
Sponsor
Oslo University Hospital
View Trial →